Question 1

What specific information will this study provide about my health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inflammasome Activation Via Circulating Metabolites clinical trial (NCT03191175). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the blood sample be collected and what will it involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inflammasome Activation Via Circulating Metabolites clinical trial (NCT03191175). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential benefits of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inflammasome Activation Via Circulating Metabolites clinical trial (NCT03191175). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks or side effects associated with participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inflammasome Activation Via Circulating Metabolites clinical trial (NCT03191175). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this study help improve treatment for people with HIV in the future?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inflammasome Activation Via Circulating Metabolites clinical trial (NCT03191175). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there any follow-up care provided after participating in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Inflammasome Activation Via Circulating Metabolites clinical trial (NCT03191175). Contact the study team or your healthcare provider for specific answers.

What this study is about